What question did this study set out to answer?

The main aim is to assess the long-term efficacy of adding a microstent to canaloplasty during cataract surgery.

April 10, 2026

One-Year Efficacy of OMNI Canaloplasty With and Without Additional Hydrus Microstent During Cataract Surgery

Key Points

The main aim is to assess the long-term efficacy of adding a microstent to canaloplasty during cataract surgery.
Compared outcomes of canaloplasty with and without a microstent over one year.
Evaluated surgical success, intraocular pressure, medication use, and safety outcomes.
Analyzed a small patient cohort with differences between groups.
No statistically significant improvements in surgical success between the two groups.
Neither the microstent nor standalone canaloplasty significantly reduced intraocular pressure.
Medication use and safety outcomes were comparable between treatment groups.

Abstract

Combining canaloplasty with a microstent did not yield statistically significant improvements in surgical success, IOP reduction, medication use, or safety outcomes at one year compared to standalone canaloplasty. This suggests that for patients undergoing CS with concurrent canaloplasty, the addition of a microstent may not confer substantial long-term clinical benefit. Small cohort size and differences in population between groups may also affect this outcome.

One-Year Efficacy of OMNI Canaloplasty With and Without Additional Hydrus Microstent During Cataract Surgery

Key Points

Abstract

Cite This Study

Also Consider

Also Consider